SecBot SecBot
6-K ·Filed Sep 14, 2026

BHST

BIOHARVEST SCIENCES INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001723464-26-000050
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine investor relations filing with no new material information. Traders should monitor the webcast for any substantive updates on the CDMO manufacturing agreement or pipeline progress, but no immediate price action is expected from this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
BHST ▲ +2.54% at T+20d
NEUTRAL call +2.54% · α vs SPY -0.19% · entry $1.78 → $1.82
Next anchor: T+60d in 6w
Latest observation: T+28 +25.08% FF3 residual α
Entry = T+0 close
Sep 14, 2026
via day close
T+1d
-6.48%
call -6.48% · α -6.04%
$1.66
settled 6w ago
T+5d
-14.93%
call -14.93% · α -17.04%
$1.51
settled 5w ago
T+20d
+2.54%
call +2.54% · α -0.19%
$1.82
settled 15d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

BioHarvest Sciences announced that CEO Zaki Rakib will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The filing is a routine investor relations announcement with no new material financial data, business developments, or guidance provided.

Key Facts

  • CEO Zaki Rakib to present at H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 4:00 PM ET.
  • Presentation will be held in-person at Lotte New York Palace Hotel, New York, NY.
  • CEO referenced 'several major advancements' in CDMO programs and 'securing our first manufacturing and supply agreement' but provided no new details or financial figures.
  • No financial results, guidance, or material business updates were disclosed in this filing.

Financial Impact

No financial figures disclosed; filing is a routine conference participation announcement.

Risk Factors

  • No new financial data or guidance was provided; the filing is purely administrative.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001723464-26-000050
Document: bhsc_ex991.htm0001723464-26-000050
Document: 0001723464-26-000050-index-headers.html0001723464-26-000050
Document: 0001723464-26-000050-index.html0001723464-26-000050
Document: 0001723464-26-000050.txt0001723464-26-000050
14 reports for BHST
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +49.52%May 14, 2026
Filters
Rows
Reports for BHST — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
6-K
BULLISH ★ 5/10
$1.75 $1.67▼ −4.18%▼ −4.64%$1.68 (−3.72%)
Oct 8, 2026
18d ago
6-K
NEUTRAL ★ 4/10
$1.50 $1.70▲ +13.71%▲ +13.99%$1.68 (+12.37%)
Sep 15, 2026
5w ago
6-K
NEUTRAL ★ 3/10
$1.66 $1.46▼ −12.05%▼ −14.61%$1.68 (+1.20%)
Sep 14, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$1.78 $1.51▼ −14.93%▼ −17.04%$1.68 (−5.35%)
Jul 15, 2026
14w ago
6-K
NEUTRAL ★ 4/10
$2.85 $2.18▼ −23.51%▼ −22.53%$1.68 (−41.05%)
Jun 18, 2026
18w ago
6-K
NEUTRAL ★ 3/10
$3.26 $2.75▼ −15.64%▼ −13.98%$1.68 (−48.47%)
May 28, 2026
21w ago
6-K
NEUTRAL ★ 3/10
$3.90 $3.56▼ −8.72%▼ −8.67%$1.68 (−56.92%)
May 14, 2026
23w ago
6-K
NEUTRAL ★ 5/10
$4.16 $3.82▼ −8.17%▼ −7.46%$1.68 (−59.62%)
May 14, 2026
23w ago
6-K
BEARISH ★ 6/10
$4.16 $3.82▲ +8.17%▲ +7.46%$1.68 (+59.62%)
May 14, 2026
23w ago
6-K
NEUTRAL ★ 3/10
$4.16 $3.82▼ −8.17%▼ −7.46%$1.68 (−59.62%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 5h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026